StockMarketWire.com - Defence contractor Chemring left its expectations unchanged amid a rise in order intakes for the year so far.
Order intake in the period to 29 February 2020 rose to £132m, up from £120m, with a book to bill ratio of 125%, down from 154%.
The Covid-19 outbreak was not currently having any material impact on the company's businesses or their supply chains. However, it said it was monitoring the situation closely.
Expected 2020 revenue was now 88% covered by period-to-date revenue and the order book, split 92% in countermeasures & energetics and 80% in sensors & information.
The order book for continuing operations stood at £478m at 29 February, up from £421m last year.
Story provided by StockMarketWire.com
Shares Magazine
Shares is the leading weekly publication for retail investors. It is packed with investment ideas, news and educational material to help build and run portfolios and get more from your money.
Investor Events
Shares puts on free Investor Events throughout the year across the country. They provide an opportunity for investors to learn more about companies on the stock market and hear from a range of investment experts including fund managers and Shares journalists.